Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 14:20 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | WV | 66 beds | Grade C | EBITDA uplift $2.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 513028 | CABELL, WV | 66 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 66-bed suburban community hospital in CABELL, WV with $35.4M in net patient revenue and a 22.5% operating margin. The hospital serves a payer mix of 65.2% Medicare, 1.0% Medicaid, and 33.8% commercial.

Thesis: Turnaround. Our ML models identify $2.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 22.5% to 29.9% (+736bps).

Net Revenue HCRIS$35.4M
Current EBITDA COMPUTED$8.0M
Operating Margin COMPUTED22.5%
Occupancy HCRIS89.4%
Revenue / Bed COMPUTED$537K
Net-to-Gross HCRIS70.7%
Distress Probability ML45.2%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
20
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 22.5% places it above the state median. Among 20 size-comparable peers (33-132 beds), the median margin is 3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (33-132), prioritizing same-state peers. 20 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)WV66$35.4M22.5%
PRINCETON COMMUNITY HOSPITALWV115$290.2M12.8%
WEIRTON MEDICAL CENTERWV127$182.4M9.4%
REYNOLDS MEMORIAL HOSPITALWV94$123.6M3.8%
BECKLEY ARHWV72$109.2M-37.8%
LOGAN REGIONAL MEDICAL CENTERWV132$104.0M3.4%
DAVIS MEMORIAL HOSPITALWV90$100.9M-20.4%
ST FRANCIS HOSPITALWV40$58.5M30.5%
GREENBRIER VALLEY MEDICAL CENTWV58$50.8M4.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$744K+210bp18mo
Cost to Collect4.5%2.5%$709K+200bp12mo
Denial Rate Reduction12.0%6.5%$702K+198bp12mo
A/R Days Reduction5200.0%3800.0%$431K+122bp9mo
Clean Claim Rate88.0%96.0%$23K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$744K
Cost to Collect
$709K
Denial Rate Reduction
$702K
A/R Days Reduction
$431K
Clean Claim Rate
$23K
Total EBITDA Uplift$2.6M
Current EBITDA$8.0M
+ RCM Uplift+$2.6M
Pro Forma EBITDA$10.6M
Current Margin22.5%
Pro Forma Margin29.9%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$12.3M$78.7M6.41x45.0%
Base (11x exit)10.0x11.0x$12.3M$90.6M7.38x49.1%
Bull Case9.0x11.0x$11.0M$103.2M9.34x56.3%
Bull (12x exit)9.0x12.0x$11.0M$115.8M10.49x60.0%
Bear Case11.0x10.0x$13.5M$61.7M4.57x35.5%
Bear (11x exit)11.0x11.0x$13.5M$72.2M5.35x39.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 65.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 20 hospitals with 33-132 beds
  • Same-state prioritization (n=21)
  • Comp margins: P25=-14.0% / P50=3.8% / P75=12.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.